Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has bee...
Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...
Singapore: Japan's Tokai Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel therapi...
Singapore: A study conducted on Biogen and Elan Pharmaceuticals's natalizumab has been shown to be effective for treatin...
Singapore: Roche and AstraZeneca entered into a collaboration to share early research data generated by Matched Molecula...
Singapore: European Medicines Agency's (EMA) Committee for Medicinal Product for Human Use (CHMP) has issued a negative ...
Singapore: HUYA Bioscience International has entered into a collaborative partnership with Shanghai Zhangjiang Biotech a...
Singapore: India-based Zydus Cadila and Pieris, a next generation therapeutic protein R&D company, have entered int...
Singapore: Kowa Pharmaceuticals America and Eli Lilly and Company revealed results of the PREVAIL study that was held in...
Singapore: Aslan Pharmaceuticals, Singapore biotech company focused on the development of immunotherapies and targeted ...
Singapore: Boehringer Ingelheim has recieved 'breakthrough therapy' designation from US Food & Drug Administration (...
Singapore: Onco Therapies Limited, a wholly-owned subsidiary ofStrides Arcolab, received final abbreviated new drug appl...
Singapore: Professor Alex Matter, CEO, Experimental Therapeutics Centre (ETC), A*STAR, Singapore, has been awarded the 8...
Singapore: China based Ascletis has received Taiwan Food and Drug Administration (TFDA) approval to start phase II clini...
Singapore: China based 3SBio has entered into an exclusive licensing deal with Korea's PharmAbcine for the development, ...
Singapore: Increased use of targeted therapies, along with a greater uptake of branded drugs and rising incidence popula...
Singapore: Global pharmaceutical company, Bristol-Myers Squibb, and California Institute for Biomedical Research (Calibr...
New Delhi: In an innovative approach to spread awareness about the need for researching new drugs for TB, OSDD, India's ...
Singapore: Australian drug discovery firm, Imugene, has appointed Mr Charles Walker as Chief Executive Officer of Imugen...
Singapore: Rapid growth in microRNA (miRNA) research over the past two years, which is fuelled by its diagnostic and the...
Singapore: VolitionRx, focused on developing blood-based diagnostic tests for a broad range of cancer types and other co...
Singapore: Japan's firm, Otsuka Pharmaceutical, has established a direct presence in Sydney, Australia, to bring innovat...
Singapore: The global prophylactic human papillomavirus (HPV) vaccine market value is forecast to experience moderate gr...
Singapore: Irish firm, Perrigo, has declined the acquisition offer from Mylan revalued at USD60 per share in cash and 2....
Singapore: Novartis' novel antimalarial drug, KAE609 (cipargamin) has shown efficacy in Phase 2 trial by demonstrating t...
Singapore: Boehringer Ingelheim has acquired investigational drug PXS4728A from Australia based Pharmaxis, to develop it...
Singapore: Australia based, Circadian Technologies, through its wholly owned subsidiary Opthea has recieved USFDA approv...
Singapore: Glioblastoma multiforme (GBM) therapeutics market in Asia-Pacific (APAC) is estimated to grow double from USD...
The US scientists have created a promising second-generation antibiotic to fight against the bacteria that commonly caus...
Singapore: Valacyclovir, a drug indicated to control the virus that causes genital herpes, appears to reduce the levels ...
Singapore: The US Food and Drug Administration (FDA) has approved US-based ViiV Healthcare's single dose Triumeq tablet...
Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designe...
Singapore: Abivax, a leading clinical stage biotech company developing and commercializing anti-viral compounds and huma...
Singapore: Japan-based Eisai recieved US FDA approval for the US supply of the epilepsy drug Fycompa (perampanel) from i...
Singapore: Johnson & Johnson (J&J) is contemplating the thought of treating depression using popular street drug...
Singapore: Impax laboratories in Taiwan recently announced that FDA had delayed its decision on Rytary, the first non-ge...
Singapore: Hironic, based out of Seoul, Korea, is an innovator of medical aesthetic laser and energy devices. The compan...
The Global Health Innovative Technology Fund (GHIT Fund) of Japan, which in the last two years has funded almost $32 mil...
Singapore: ASLAN Pharmaceuticals, Singapore based biotech company focused on the development of immunotherapies and targ...
Singapore: A team from A*STAR's Institute of Chemical and Engineering Sciences (ICES) and National University Hospital (...
Singapore: Novartis Pharma KK has found no evidence that data on clinical trials for its hypertension drug Diovan had be...
Singapore: Boehringer Ingelheim and Eli Lilly's investigational Type 2 Diabetes (T2D) drug dipeptidyl peptidase-4 (DPP-4...
Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch ...
Singapore: Australian drug delivery company, Phosphagenics, has raised $11.45 million of its $15.29 million capital rais...
Singapore: Patrys, Australia's clinical stage biopharmaceutical company, has received approval to progress its phase I/I...
Singapore: Eisai has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare (M...
Singapore: GIDEON (Global Investigation of therapeutic Decisions in hepatocellular carcinoma and of its treatment with s...
Mumbai: Cipla along with the non-profit R&D organization, Drugs for Neglected Diseases initiative (DNDi), revealed t...
Singapore: Boston Strategics Corp (BSC), a clinical-stage drug research and development (R&D) company has signed an ...
Singapore: Associate Professor Matthias Ernst and colleagues from Australia's Walter and Eliza Hall Institute have ident...
Singapore: ASLAN Pharmaceuticals has obtained the global rights to Almirall's DHODH inhibitor, LAS186323, currently in p...
Singapore: Professor Ian Frazer and his team at the University of Queensland, have been awarded grant from Australia's N...
According to the Global Burden of Disease and Risk Factors (World Bank Publications, 2006), infectious diseases are one ...
Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatme...
Singapore: India based drug company, Zydus, has initiated Phase III trials of Lipaglyn (Saroglitazar) to evaluate its sa...
Singapore: Melbourne-based biopharmaceutical company Specialised Therapeutics Australia (STA) has been granted exclusive...
Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acqu...
Singapore: Glenmark Pharmaceuticals, a research-driven, global integrated pharmaceutical company announced that its nove...
Singapore: US-based Avantor Performance Materials has introduced a higher purity Super Refined grade of polysorbate prod...
Singapore: Novartis Foundation for Sustainable Development (NFSD) has launched a new leprosy strategy focused on interru...
Singapore: AstraZeneca and NN Petrov Institute of Oncology, one of Russia's leading cancer research institutions, signed...
Singapore: A rapid heart rate is a common condition among elderly individuals, and represents a potential goldmine for p...
Singapore: Experimental Therapeutics Center (ETC) and Exploit Technologies of Agency for Science, Technology and Researc...
Singapore: The US Food and Drug Administration (FDA) has approved Stribild, a complete once-daily single tablet regimen ...
Singapore: Bionomics is going to present clinical trial data from its ongoing US trial of BNC105 in patients with metast...
Singapore: QRxPharma received complete response letter (CRL) regarding the company's Moxduo new drug application (NDA) f...
Singapore: 3SBio, China based biotechnology company, has signed license agreement with JenKem Technology to develop, man...
Singapore: Japanese firm Takeda Pharmaceutical has formed a research collaboration with the BC Cancer Agency to explore ...
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...
Singapore: The Japanese government has plans to help private-sector companies in exporting as early as 2015 regenerative...
Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging ...
Singapore: Australia-based GI Dynamics has conducted a new meta-analysis that demonstrates EndoBarrier Therapy, an endos...
Singapore: Data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented ...
Singapore: The Korea Drug Development Fund (KDDF) has chosen PAREXEL International, a leading global biopharmaceutical s...
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...
Singapore: Glaxosmithkline declared that the phase III study of two anti-HER2 agents lapatinib and trastuzumab did not m...
Singapore: Focusing on the medical application of nanotechnology, Nanyang Technological University (NTU) in Singapore ...
Singapore: The National Institutes of Health (NIH), US, plans to invest an additional $100 million over the next three ...
Singapore: Almac said that Asian clinical trials must adopt highest GMP and GDP standards. Speaking to a news report, Mr...
Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...
Excelra, headquartered in Hyderabad, India, has announced its collaboration with H M Pharma Consultancy (HMPC), a life s...
Singapore: Boehringer Ingelheim Biopharmaceuticals has installed a fast track process transfer to commercial scale. Comp...
Singapore: US Food and Drug Administration (FDA) has approved Merck's RAGWITEK Tablet indicated as immunotherapy for the...
Singapore: Australian drug development company Agenix has appointed international biomedical business development expert...
Singapore: France-based biopharma company NovAliX entered into a fragment-based drug discovery alliance with Kyowa Hakko...
Singapore: Genentech, a member of the Roche Group, has achieved primary endpoint of a significant improvement in HER2-po...
Singapore: Prostate cancer is becoming increasingly common due to globally growing numbers of elderly men, and scientist...
Singapore: Australian therapeutic goods administration (TGA) has approved Aubagio (teriflunomide) 14 mg as a new once-da...
Singapore: A former employee of the Japanese drug maker Novartis, was arrested with allegations of data manipulation. So...
Eisai's UK subsidiary, Eisai Europe, has received a positive opinion from the European Medicines Agency's Committee for ...
Singapore: Takeda Pharmaceutical and H. Lundbeck A/S have submitted a new drug application (NDA) to the US Food and Drug...
Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a po...
Singapore: The US FDA has approved GSK and Pfizer-owned HIV dedicated firm, ViiV Healthcare's, Tivicay (dolutegravir) 50...
Singapore: FibroGen and Japanese company Astellas Pharma have initiated the first clinical study in the phase III clinic...
Singapore: Antisense Therapeutics, an Australian publicly listed biopharmaceutical drug discovery and development compan...
Singapore: US FDA has acknowledged the resubmission of a New Drug Application (NDA) for ezetimibe and atorvastatin table...
Singapore: Eli Lilly and Company has outlined its strategies to face patent cliff expected in 2014. In a statement to in...
Singapore: Asia share of global GDP, measured in purchasing power, has increased from 26.8 percent in 2001 to 33.8 perce...
Singapore: Novo Nordisk's 56-week double-blind phase IIIa clinical trial with liraglutide has shown that it has the pote...
Singapore: A novel anti-TB drug has generated encouraging results in a recent Phase II trial funded by the non-profit TB...
